BRIVIACT

This brand name is authorized in Austria, Australia, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug BRIVIACT contains one active pharmaceutical ingredient (API):

1 Brivaracetam UNII U863JGG2IA - BRIVARACETAM

Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A), a transmembrane glycoprotein found at presynaptic level in neurons and in endocrine cells. Although the exact role of this protein remains to be elucidated it has been shown to modulate exocytosis of neurotransmitters. Read about Brivaracetam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BRIVIACT Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX23		N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11327E, 11328F, 11334M, 11338R, 11339T, 11349H, 11350J, 11356Q, 11357R, 11358T
Country: EE	Ravimiamet	Identifier(s): 1708781, 1708792, 1708804, 1708815, 1708826, 1708837, 1708848, 1708859, 1708860, 1708871, 1708882, 1708893, 1708905, 1708916, 1708927, 1708938, 1708949, 1708950, 1708961, 1708972, 1709018, 1709029, 1849710, 1849721
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1151073006, 1151073010, 1151073014, 1151073018, 1151073021, 1151073022
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 144024, 157197, 388813, 460137, 486271, 525456, 560527
Country: FR	Base de données publique des médicaments	Identifier(s): 60579228, 63546596, 64002423, 64065772, 64872342, 65519142, 67429003
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 314998, 315007, 315014, 315024, 315029, 315075, 319281, 367630, 367632, 367634, 374315, 374317, 374319, 376227, 376229, 377163, 381223, 381225, 381227, 391520, 391522
Country: HK	Department of Health Drug Office	Identifier(s): 65938, 65939, 65940, 65941, 65942, 65943
Country: IE	Health Products Regulatory Authority	Identifier(s): 44021, 44022, 44023, 44024, 44026, 44027, 44029
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8359, 8361, 8362, 8363, 8364, 8465
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1079518, 1079519, 1079520, 1079521, 1079522, 1079523, 1079524, 1079525, 1079526, 1079527, 1079528, 1079529, 1079531, 1079532, 1079533, 1079534, 1079535, 1079536, 1079537, 1079538, 1079539, 1079540, 1080494, 1080495, 1080496, 1080497, 1080498
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 379M2016, 386M2016
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 131954, 131962, 131970, 131989, 131997, 132004
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100368820, 100368837, 100368843, 100368850, 100368866, 100368872, 100368889
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63823001, W63824001, W63825001, W63826001, W63827001, W63828001, W63829001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699624090188, 8699624090195, 8699624090201, 8699624090218, 8699624090225, 8699624090232, 8699624090249, 8699624090256, 8699624090263, 8699624090270, 8699624090287, 8699624090294, 8699624090300, 8699624090317, 8699624090324, 8699624650085, 8699624770011
Country: US	FDA, National Drug Code	Identifier(s): 50474-370, 50474-470, 50474-570, 50474-670, 50474-770, 50474-870, 50474-970